Logo

Surmodics, Inc.

SRDX

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modificati… read more

Healthcare

Medical Devices

25 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$37.46

Price

-0.48%

-$0.18

Market Cap

$535.588m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$121.575m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$19.863m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$1.39

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$110.246m

$163.214m

Assets

$52.968m

Liabilities

$32.808m

Debt
Debt to Assets

20.1%

-5.7x

Debt to EBITDA
Free Cash Flow

-$7.442m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases